NCT01179607View on ClinicalTrials.gov

Study of Efficacy of a Vasopressin 2 Receptor Antagonist M0002 for Treatment of Ascites in Cirrhotic Subjects With Hypo- or Normonatraemia

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Cirrhotic Ascites
Interventions
DRUG

M0002

DRUG

Placebo

Sponsors

Lead Sponsor

Movetis
All Listed Sponsors
lead

Movetis

INDUSTRY